Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析

◆英語タイトル:Mangalam Drugs and Organics Ltd (MANGALAM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH202600FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥80,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥120,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mangalam Drugs and Organics Ltd (MDOL) carries out manufacturing and supplying of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company’s active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, artemether, dihydroartemisinin, hydroxy chloroquine sulphate, furosemide, pregabalin, and lumefantrine, among others. Its intermediates comprises 4, 7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. MDOL operates through its manufacturing facilities located across India. The company distributes its products through its distributors located across India. MDOL is headquartered in Mumbai, Maharashtra, India.

Mangalam Drugs and Organics Ltd Key Recent Developments

Mar 21,2021: Mangalam Drugs and Organics announces appointment of Dr. Praveen Saxena
Dec 07,2020: Mangalam Drugs and Organics : Resignation of Independent Director of the Company
Nov 21,2020: Mangalam Drugs and Organics: Change in Directorate

This comprehensive SWOT profile of Mangalam Drugs and Organics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mangalam Drugs and Organics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mangalam Drugs and Organics Ltd – Key Information
Mangalam Drugs and Organics Ltd – Overview
Mangalam Drugs and Organics Ltd – Key Employees
Mangalam Drugs and Organics Ltd – Key Employee Biographies
Mangalam Drugs and Organics Ltd – Key Operational Heads
Mangalam Drugs and Organics Ltd – Major Products and Services
Mangalam Drugs and Organics Ltd – History
Mangalam Drugs and Organics Ltd – Company Statement
Mangalam Drugs and Organics Ltd – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mangalam Drugs and Organics Ltd – Business Description
Mangalam Drugs and Organics Ltd – Corporate Strategy
Mangalam Drugs and Organics Ltd – SWOT Analysis
SWOT Analysis – Overview
Mangalam Drugs and Organics Ltd – Strengths
Mangalam Drugs and Organics Ltd – Weaknesses
Mangalam Drugs and Organics Ltd – Opportunities
Mangalam Drugs and Organics Ltd – Threats
Mangalam Drugs and Organics Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Mangalam Drugs and Organics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mangalam Drugs and Organics Ltd, Key Information
Mangalam Drugs and Organics Ltd, Key Ratios
Mangalam Drugs and Organics Ltd, Share Data
Mangalam Drugs and Organics Ltd, Major Products and Services
Mangalam Drugs and Organics Ltd, History
Mangalam Drugs and Organics Ltd, Key Employees
Mangalam Drugs and Organics Ltd, Key Employee Biographies
Mangalam Drugs and Organics Ltd, Key Operational Heads
Mangalam Drugs and Organics Ltd, Other Locations
Mangalam Drugs and Organics Ltd, Subsidiaries

Mangalam Drugs and Organics Ltd, Key Competitors
Mangalam Drugs and Organics Ltd, SWOT Analysis
Mangalam Drugs and Organics Ltd, Ratios based on current share price
Mangalam Drugs and Organics Ltd, Annual Ratios
Mangalam Drugs and Organics Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lixte Biotechnology Holdings Inc (LIXT):企業の財務・戦略的SWOT分析
    Lixte Biotechnology Holdings Inc (LIXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ezaki Glico Co Ltd:企業の戦略・SWOT・財務情報
    Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Century Aluminum Co:企業の戦略・SWOT・財務情報
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • Randgold Resources Limited:企業の戦略・SWOT・財務情報
    Randgold Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Randgold Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Ameresco Inc (AMRC):電力:M&Aディール及び事業提携情報
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sino Gas & Energy Holdings Ltd (SEH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Comcast Corp (CMCSA):企業の財務・戦略的SWOT分析
    Comcast Corp (CMCSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Banco Bradesco SA:企業の戦略・SWOT・財務情報
    Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報
    Summary EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services …
  • Indutrade AB (INDT):企業の財務・戦略的SWOT分析
    Summary Indutrade AB (Indutrade) is an industrial goods company that develops and sells high-tech products and solutions. It carries out acquisition of technology companies. The company acquired companies that manufacture springs, press work, valve channels, piston rings, pipes and pipe systems, ind …
  • Arsenal Holdings plc:企業の戦略的SWOT分析
    Arsenal Holdings plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ConocoPhillips (COP):企業の財務・戦略的SWOT分析
    ConocoPhillips (COP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oral Health Products, Inc.:企業の戦略・SWOT・財務情報
    Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GWA Group Limited (GWA):企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mercer LLC:企業のM&A・事業提携・投資動向
    Mercer LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercer LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆